The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates

Abstract Background Reproducible, high-quality surgery is a key point in the management of cancer patients. Quality indicators for surgical treatment melanoma has been presented with benchmarks but data on morbidity are still limited. This study presents quality after non-metastatic skin an Italian registry. Methods Data were extracted from Central National Melanoma Registry (CNMR) promoted by Intergroup (IMI). All procedures (WE, SNLB or LFND) between January 2011 and February 2017 evaluated inclusion study. Only centers adequate completeness information (> 80%) included Short-term complications (wound infection, dehiscence, graft failure seroma) investigated. Results Wound infection rate was 1.1% (0.4 to 2.7%) WE, 1.3% (0.7 2.5%) SLNB 4.1% (2.1 8.0%) LFND. dehiscence 2.0% (0.8 5.1%) 0.9% (0.2 3.0%) 2.8% (0.9 8.6%) Seroma 4.2% (1.5 11.1%) 15.1% (4.6 39.9%) Unreliable found failure. Conclusions Our findings contribute available literature setting up recommended standards centers, thus improving offered A consensus core issues around needed provide practical guidance prevention management.